296 related articles for article (PubMed ID: 29626115)
1. Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3.
Zhang X; Wang Y; Yuan J; Li N; Pei S; Xu J; Luo X; Mao C; Liu J; Yu T; Gan S; Zheng Q; Liang Y; Guo W; Qiu J; Constantin G; Jin J; Qin J; Xiao Y
J Exp Med; 2018 May; 215(5):1365-1382. PubMed ID: 29626115
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Factor Receptor Family 6/Nuclear Factor-κB) in a Rat Model of Subarachnoid Hemorrhage.
Luo Y; Fang Y; Kang R; Lenahan C; Gamdzyk M; Zhang Z; Okada T; Tang J; Chen S; Zhang JH
Stroke; 2020 Nov; 51(11):3320-3331. PubMed ID: 32933418
[TBL] [Abstract][Full Text] [Related]
3. Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.
Zhou T; Sun Y; Li M; Ding Y; Yin R; Li Z; Xie Q; Bao S; Cai W
Cell Death Dis; 2018 May; 9(6):590. PubMed ID: 29789597
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain.
An Q; Sun C; Li R; Chen S; Gu X; An S; Wang Z
J Neuroinflammation; 2021 May; 18(1):117. PubMed ID: 34020664
[TBL] [Abstract][Full Text] [Related]
5. Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis.
Liu Y; Peng J; Sun T; Li N; Zhang L; Ren J; Yuan H; Kan S; Pan Q; Li X; Ding Y; Jiang M; Cong X; Tan M; Ma Y; Fu D; Cai S; Xiao Y; Wang X; Qin J
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3796-E3805. PubMed ID: 28439030
[TBL] [Abstract][Full Text] [Related]
6. Abnormally elevated EZH2-mediated H3K27me3 enhances osteogenesis in aortic valve interstitial cells by inhibiting SOCS3 expression.
Xie K; Zeng J; Wen L; Peng X; Lin Z; Xian G; Guo Y; Yang X; Li P; Xu D; Zeng Q
Atherosclerosis; 2023 Jan; 364():1-9. PubMed ID: 36455343
[TBL] [Abstract][Full Text] [Related]
7. Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation.
Zhou J; Huang S; Wang Z; Huang J; Xu L; Tang X; Wan YY; Li QJ; Symonds ALJ; Long H; Zhu B
Nat Commun; 2019 Jun; 10(1):2427. PubMed ID: 31160593
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.
Wei L; Liu Q; Huang Y; Liu Z; Zhao R; Li B; Zhang J; Sun C; Gao B; Ding X; Yu X; He J; Sun A; Qin Y
Int J Biochem Cell Biol; 2020 Mar; 120():105685. PubMed ID: 31917284
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
[TBL] [Abstract][Full Text] [Related]
10. Repressing the repressor: Ezh2 mediates macrophage activation.
Neele AE; de Winther MPJ
J Exp Med; 2018 May; 215(5):1269-1271. PubMed ID: 29691302
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 Reduced Microglial Activation and Mitochondrial Dysfunction to Alleviate Depression-Like Behaviour Via the GAS5/EZH2/SOCS3/NRF2 Axis.
Li J; Gao W; Zhao Z; Li Y; Yang L; Wei W; Ren F; Li Y; Yu Y; Duan W; Li J; Dai B; Guo R
Mol Neurobiol; 2022 May; 59(5):2855-2873. PubMed ID: 35230663
[TBL] [Abstract][Full Text] [Related]
12. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of EZH2 by a small molecule inhibitor regulates microglial gene expression essential for inflammation.
Arifuzzaman S; Das A; Kim SH; Yoon T; Lee YS; Jung KH; Chai YG
Biochem Pharmacol; 2017 Aug; 137():61-80. PubMed ID: 28431938
[TBL] [Abstract][Full Text] [Related]
14. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation.
Bamidele AO; Svingen PA; Sagstetter MR; Sarmento OF; Gonzalez M; Braga Neto MB; Kugathasan S; Lomberk G; Urrutia RA; Faubion WA
Cell Mol Gastroenterol Hepatol; 2019; 7(1):55-71. PubMed ID: 30510991
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Ezh2 In Vitro and the Decline of
Hong F; Zhao M; Zhang L; Feng L
Stem Cells Dev; 2019 May; 28(10):649-658. PubMed ID: 30887911
[TBL] [Abstract][Full Text] [Related]
16. Protein arginine methyltransferase 2 (PRMT2) promotes dextran sulfate sodium-induced colitis by inhibiting the SOCS3 promoter via histone H3R8 asymmetric dimethylation.
Li J; Pan X; Ren Z; Li B; Liu H; Wu C; Dong X; de Vos P; Pan LL; Sun J
Br J Pharmacol; 2022 Jan; 179(1):141-158. PubMed ID: 34599829
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract.
Wang B; Liu Y; Luo F; Xu Y; Qin Y; Lu X; Xu W; Shi L; Liu Q; Xiang Q
Arch Toxicol; 2016 Feb; 90(2):449-61. PubMed ID: 25526925
[TBL] [Abstract][Full Text] [Related]
18. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
Bhasin M; Wu M; Tsirka SE
BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
[TBL] [Abstract][Full Text] [Related]
19. Myeloid Ezh2 Deficiency Limits Atherosclerosis Development.
Neele AE; Chen HJ; Gijbels MJJ; van der Velden S; Hoeksema MA; Boshuizen MCS; Van den Bossche J; Tool AT; Matlung HL; van den Berg TK; Lutgens E; de Winther MPJ
Front Immunol; 2020; 11():594603. PubMed ID: 33574814
[TBL] [Abstract][Full Text] [Related]
20. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
